← Back to Search

Balloon Catheter

Ringer Perfusion Balloon Catheter for Coronary Artery Stenosis

N/A
Waitlist Available
Led By Kathleen Kearney, MD
Research Sponsored by Vascular Solutions LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during procedure
Awards & highlights

Study Summary

This trial is testing whether a Ringer perfusion balloon catheter is safe and effective for dilating coronary stenoses during PCI.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and during procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Coronary Stenosis
Rate of clinically relevant events
Secondary outcome measures
Ringer Inflation
Successful PCI
TIMI Flow

Trial Design

1Treatment groups
Experimental Treatment
Group I: ExperimentalExperimental Treatment1 Intervention
Adult subjects clinically indicated for non-emergent percutaneous coronary intervention (PCI) as a stand-alone procedure or following non-emergent diagnostic angiography performed during the same procedure that, in the physician's estimation, requires prolonged balloon inflation with distal perfusion.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ringer Perfusion Balloon Catheter
2022
N/A
~60

Find a Location

Who is running the clinical trial?

Vascular Solutions LLCLead Sponsor
8 Previous Clinical Trials
722 Total Patients Enrolled
Ridardo DeMedeiros, PhDStudy DirectorTeleflex
Kathleen Kearney, MDPrincipal InvestigatorUniversity of Washington
~20 spots leftby May 2025